Arcutis Biotherapeutics, Inc. (ARQT)
29.45
-0.32
(-1.07%)
USD |
NASDAQ |
Dec 11, 16:00
29.44
-0.01
(-0.03%)
After-Hours: 17:54
Arcutis Biotherapeutics Research and Development Expense (Quarterly): 19.60M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 1.528M |
| ANI Pharmaceuticals, Inc. | 12.30M |
| CorMedix, Inc. | 5.098M |
| Editas Medicine, Inc. | 19.05M |
| Syndax Pharmaceuticals, Inc. | 56.28M |